Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 511-520 of 1154 total displayed.

Past content (since Jan 1999):

Basic Science Reports
Activation of Matrix Metalloproteinases Precedes Left Ventricular Remodeling in Hypertensive Heart Failure Rats: Its Inhibition as a Primary Effect of Angiotensin-Converting Enzyme Inhibitor
Yasushi Sakata, Kazuhiro Yamamoto, Toshiaki Mano, Nagahiro Nishikawa, Junichi Yoshida, Masatsugu Hori, Takeshi Miwa, and Tohru Masuyama
Circulation 2004;109:2143-2149; published online before print as doi:10.1161/01.CIR.0000125741.88712.77 [Abstract] [Full text]  

Correspondence
Why Did the Anti-C5 Complement Antibody Pexelizumab Not Reduce Infarct Size but Influence Clinical Outcomes Positively When Applied as Adjunctive Therapy to Primary Percutaneous Coronary Intervention? Response
Jiri T. Beranek, Christopher B. Granger, Kenneth W. Mahaffey, W. Douglas Weaver, Pierre Theroux, Judith S. Hochman, Thomas G. Filloon, Thomas G. Todaro, Scott Rollins, Christopher F. Mojcik, Jose C. Nicolau, Witold Ruzyllo, and Paul W. Armstrong
Circulation 2004;109:e195-196e, doi:10.1161/01.CIR.0000127111.19811.F9 [Full text]  

Articles
Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice
Tsuyoshi Hattori, Hiroaki Shimokawa, Midoriko Higashi, Junko Hiroki, Yasushi Mukai, Hiroyuki Tsutsui, Kozo Kaibuchi, and Akira Takeshita
Circulation published April 19, 2004, doi:10.1161/01.CIR.0000127939.16111.58 [Abstract]  

Correspondence
Aldosterone Levels After Angiotensin Receptor Blocker Treatment Response
Richard J. Folkeringa, Yigal M. Pinto, Harry J.G.M. Crijns, Jay N. Cohn, Inder S. Anand, Roberto Latini, Serge Masson, Yann-Tong Chiang, and Robert Glazer
Circulation 2004;109:e182, doi:10.1161/01.CIR.0000124885.70372.41 [Full text]  

Basic Science Reports
gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension
O. Jung, J.G. Schreiber, H. Geiger, T. Pedrazzini, R. Busse, and R.P. Brandes
Circulation 2004;109:1795-1801; published online before print as doi:10.1161/01.CIR.0000124223.00113.A4 [Abstract] [Full text]  

Basic Science Reports
Long-Term Heart Rate Reduction Induced by the Selective If Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure
Paul Mulder, Stephane Barbier, Abdeslam Chagraoui, Vincent Richard, Jean Paul Henry, Françoise Lallemand, Sylvanie Renet, Guy Lerebours, Florence Mahlberg-Gaudin, and Christian Thuillez
Circulation 2004;109:1674-1679; published online before print as doi:10.1161/01.CIR.0000118464.48959.1C [Abstract] [Full text]  

Clinical Investigations and Reports
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
The AFFIRM Investigators
Circulation 2004;109:1509-1513; published online before print as doi:10.1161/01.CIR.0000121736.16643.11 [Abstract] [Full text]  

Articles
Activation of Matrix Metalloproteinases Precedes Left Ventricular Remodeling in Hypertensive Heart Failure Rats. Its Inhibition as a Primary Effect of Angiotensin-Converting Enzyme Inhibitor
Yasushi Sakata, Kazuhiro Yamamoto, Toshiaki Mano, Nagahiro Nishikawa, Junichi Yoshida, Masatsugu Hori, Takeshi Miwa, and Tohru Masuyama
Circulation published March 29, 2004, doi:10.1161/01.CIR.0000125741.88712.77 [Abstract]  

Basic Science Reports
Cyclooxygenase-2 Inhibitor Treatment Improves Left Ventricular Function and Mortality in a Murine Model of Doxorubicin-Induced Heart Failure
Reynolds M. Delgado, III, Mohamad A. Nawar, Aly M. Zewail, Biswajit Kar, William K. Vaughn, Kenneth K. Wu, Nena Aleksic, Natarajan Sivasubramanian, Kathleen McKay, Douglas L. Mann, and James T. Willerson
Circulation 2004;109:1428-1433; published online before print as doi:10.1161/01.CIR.0000121354.34067.48 [Abstract] [Full text]  

Articles
gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension
O. Jung, J. G. Schreiber, H. Geiger, T. Pedrazzini, R. Busse, and R. P. Brandes
Circulation published March 22, 2004, doi:10.1161/01.CIR.0000124223.00113.A4 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment